动脉瘤
特里夫
生物
干扰素
病毒学
先天免疫系统
细胞生物学
免疫系统
免疫学
传染病(医学专业)
疾病
2019年冠状病毒病(COVID-19)
医学
病理
Toll样受体
作者
Rissar Siringo Ringo,Amonrat Choonnasard,Tamaki Okabayashi,Akatsuki Saito
标识
DOI:10.20944/preprints202407.0166.v1
摘要
Arterivirus can establish persistent infection in animals such as equids, pigs, nonhuman primates, rodents, and possums. Some Arterivirus can even cause overt and severe diseases such as Equine Arteritis in horses and Porcine Reproductive and Respiratory Syndrome in pigs, leading to huge economic losses. Arterivirus have evolved viral proteins to antagonize the host cell’s innate immune responses by inhibiting type I interferon (IFN) signaling, assisting viral evasion and persistent infection. So far, the role of the Arterivirus glycoprotein 5 (GP5) protein in IFN signaling inhibition remains unclear. Here, we investigated the inhibitory activity of 47 Arterivirus GP5 proteins derived from various hosts. We demonstrated that all GP5 proteins showed conserved activity for antagonizing TIR-domain-containing adapter protein inducing interferon-β (TRIF)-mediated IFN- signaling through TRIF degradation. In addition, Arterivirus GP5 proteins showed conserved inhibitory activity against IFN-β signaling, induced by either pig or human TRIF. Furthermore, certain Arterivirus GP5 proteins could inhibit the induction of IFN-stimulated genes. These findings highlight the role of Arterivirus GP5 proteins in supporting persistent infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI